TEL AVIV, Israel & PARSIPPANY, N.J., March 07, 2023–(Business WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) right now declared that Eli Kalif, EVP and Main Monetary Officer will existing at the Barclays International Healthcare Meeting on Tuesday, March 14, 2023. The presentation will start out at 10:15 A.M. Japanese Time.
To access a stay webcast of the presentation, stop by Teva’s Investor Relations web page at https://ir.tevapharm.com/Functions-and-Presentations.
An archived model of the webcast will be obtainable in 24 hrs following the conclusion of the stay discussion and will be accessible for up to 90 days.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been acquiring and creating medicines to increase people’s life for much more than a century. We are a world leader in generic and innovative medications with a portfolio consisting of in excess of 3,500 products in practically each therapeutic space. Close to 200 million persons around the earth choose a Teva medicine every single working day, and are served by 1 of the major and most sophisticated source chains in the pharmaceutical business. Alongside with our founded presence in generics, we have important ground breaking medications exploration and operations supporting our escalating portfolio of innovative medications and biopharmaceutical goods. Learn more at www.tevapharm.com.
Cautionary Observe Concerning Forward-Looking Statements
This document and the meeting get in touch with could comprise forward-on the lookout statements in the indicating of the Private Securities Litigation Reform Act of 1995, which are based on management’s present beliefs and anticipations and are topic to significant dangers and uncertainties, the two recognized and not known, that could cause our potential success, efficiency or achievements to differ significantly from that expressed or implied by these types of ahead-seeking statements. Vital elements that could trigger or add to this kind of variances include things like challenges relating to: our potential to productively compete in the marketplace our substantial indebtedness our business and operations in general which include: the impact of international economic conditions and other macroeconomic developments and the governmental and societal responses thereto compliance, regulatory and litigation issues other financial and economic threats and other elements mentioned in our Yearly Report on Kind 10-K for the 12 months finished December 31, 2022, like in the sections captioned “Hazard Elements.” Forward-seeking statements speak only as of the day on which they are made, and we presume no obligation to update or revise any ahead-seeking statements or other info contained herein, whether as a final result of new facts, foreseeable future events or or else. You are cautioned not to set undue reliance on these forward-seeking statements.
See supply edition on businesswire.com: https://www.businesswire.com/information/residence/20230307005198/en/
Ran Meir +1 (267) 468-4475
Sanjeev Sharma +1 (973) 658 2700
Yael Ashman +972 (3) 914 8262
Kelley Dougherty +1 (973) 832-2810
Eden Klein +972 (3) 906 2645